Tandem Diabetes Care, Inc.
TNDM
$21.55
-$0.04-0.19%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.50% | 3.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.50% | 3.56% | |||
| Cost of Revenue | 6.93% | 0.12% | |||
| Gross Profit | 24.70% | 6.70% | |||
| SG&A Expenses | 6.26% | -2.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.74% | -1.18% | |||
| Operating Income | 141.34% | 37.03% | |||
| Income Before Tax | 118.62% | 56.44% | |||
| Income Tax Expenses | 232.50% | 25.25% | |||
| Earnings from Continuing Operations | 97.22% | 59.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 97.22% | 59.61% | |||
| EBIT | 141.34% | 37.03% | |||
| EBITDA | 182.14% | 43.37% | |||
| EPS Basic | 97.22% | 59.96% | |||
| Normalized Basic EPS | 120.83% | 41.38% | |||
| EPS Diluted | 97.22% | 59.96% | |||
| Normalized Diluted EPS | 120.83% | 41.38% | |||
| Average Basic Shares Outstanding | 0.54% | 0.90% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||